Lung Cancer Europe will hold an event on 28th November at the EU Parliament to highlight the current challenges in clinical trials across Europe Within the occasion of this event, the 3rd edition of the LuCE report, which highlights some of the challenges still faced regarding research, will be presented. For the third consecutive year, LuCE will hold an event at […]
Category Archives: News
According to Globocan 2018, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths). In November all stakeholders mark the Lung Cancer Awareness Month and Lung Cancer Europe will continue to raise awareness about inequities regarding the access to lung […]
LuCE president, Stefania Vallone provided an insight analysis on “Being heard over the noise: The patient viewpoint” during #ESMO2018. She emphasized the role can patients and patient organizations play within the new therapies development and reimbursement. According to her, in lung cancer, time matters for patient, thus early diagnosis is crucial for a good prognosis. Anyhow, with patients who do/have […]
We invite all interested ESMO members to visit us @LuCE booth located in the society village at ESMO 2018 in Munich. Name: LuCE Hall: B1 Stand: PA 8 LuCE team will answer your questions and will provide materials and information about #lungcancer. Check out the map 1 and map 2 to easily find us.